EP Patent
EP3580198B1 — A process for preparation of1-[2-(dimethylamino)-1-(4-hydroxyphenyl) ethyl]-cyclohexanol and salts thereof
Assigned to R L Finechem Private Ltd · Expires 2023-08-09 · 3y expired
What this patent protects
Patent listed against Pristiq.
Drugs covered by this patent
- Pristiq (Desvenlafaxine Succinate) · Pfizer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.